why choose us

First received: June 30, 2023

Clinical Trial: Cold Atmospheric Plasma Device Extension Study

Study Status: Completed

Recruit Status: RECRUITING

Condition: Verruca Vulgaris

Study Type: INTERVENTIONAL


Official Title: Cold Atmospheric Plasma Device for the Treatment of Molluscum Contagiosum and Verruca Vulgaris in Pediatric Patients - Open-Label Extension Study

Brief Summary: Patients between 4-21 years of age with at least one wart or molluscum lesion are eligible to participate in this study.The duration of the study is a minimum of 4 weeks with the maximum duration of monthly treatments for one year, depending on lesion clearance.The number of lesions will be chosen by the dermatologist.Patients who opt to participate will receive non-thermal, or cold, atmospheric plasma to treat all lesions selected.Safety profile as well as changes in size, pain and appearance will be…

Read more